S&P SmallCap 600 Pure Growth Fund TGTX Holdings History
S&P SmallCap 600 Pure Growth Fund's TG Therapeutics Inc Holding Summary
As of 2025-03-31, RYDEX SERIES FUNDS held 1,658.00 shares of TG Therapeutics Inc(TGTX), totaling $65,370.00. This investment constitutes 2.02% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0% of the outstanding TG Therapeutics Inc(TGTX) stock.
The initial trade took place in 2024Q3. And since then S&P SmallCap 600 Pure Growth Fund has made 1 purchases of TGTX, at an average price of $21.82, for a total of 2,332.00 shares. In addition, there have been 2 sales at an average price of $30.57 for 674.00 shares. Based on historical transaction data and TGTX's current price of $37.91, S&P SmallCap 600 Pure Growth Fund's estimated gain on his TGTX holdings is $32,575.42, reflecting a 64.02% gain to date.
S&P SmallCap 600 Pure Growth Fund TGTX ($37.91) Holding Chart
S&P SmallCap 600 Pure Growth Fund TGTX ($37.91) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
